KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Times Interest Earned (2016 - 2026)

Esperion Therapeutics filings provide 7 years of Times Interest Earned readings, the most recent being $3.77 for Q4 2025.

  • On a quarterly basis, Times Interest Earned rose 2200.52% to $3.77 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.71, a 11.62% decrease, with the full-year FY2025 number at $0.71, down 22.41% from a year prior.
  • Times Interest Earned hit $3.77 in Q4 2025 for Esperion Therapeutics, up from -$0.45 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $5.15 in Q1 2024 to a low of -$10.19 in Q1 2021.
  • Median Times Interest Earned over the past 5 years was -$2.68 (2023), compared with a mean of -$1.9.
  • The widest YoY moves for Times Interest Earned: up 2200.52% in 2025, down 122.07% in 2025.
  • Esperion Therapeutics' Times Interest Earned stood at -$4.14 in 2021, then increased by 28.37% to -$2.97 in 2022, then grew by 5.16% to -$2.81 in 2023, then surged by 93.63% to -$0.18 in 2024, then soared by 2200.52% to $3.77 in 2025.
  • The last three reported values for Times Interest Earned were $3.77 (Q4 2025), -$0.45 (Q3 2025), and $0.35 (Q2 2025) per Business Quant data.